Section Arrow
ALEC.NASDAQ
- Alector
Quotes are at least 15-min delayed:2025/04/14 09:57 EDT
Last
 0.984
+0.034 (+3.58%)
Day High 
Prev. Close
0.95 
1-M High
1.58 
Volume 
48.91K 
Bid
0.9832
Ask
0.9849
Day Low
0.9645 
Open
0.9768 
1-M Low
0.87 
Market Cap 
94.13M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 1.05 
20-SMA 1.19 
50-SMA 1.46 
52-W High 6.78 
52-W Low 0.87 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.23/-1.66
Enterprise Value
127.90M
Balance Sheet
Book Value Per Share
1.28
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
100.56M
Operating Revenue Per Share
0.97
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
PTNPalatin Technologies0.192+0.027+16.36%-- 
THTXTheratechnologies3.041+1.101+56.75%-- 
VERVVerve Therapeutics3.775+0.515+15.80%-- 
ARTLArtelo Biosciences1.2901+0.4682+56.97%-- 
RXRXRecursion Pharmaceuticals5.6014-0.1586-2.75%-- 
Quotes are at least 15-min delayed:2025/04/14 09:57 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.